MDMA Assisted Psychotherapy Explained by Rick Dublin of MAPS

By Hash Borgir | March 17, 2017

MDMA assisted psychotherapy

Psychedelic drugs, particularly MDMA, might be the answer to our mental health prayers. Contrary to the popular notion that psychedelic drugs are just for hippies looking to party, or that they cause unrecoverable psychosis, many psychedelic drugs have valid clinical uses. With the continued war on drugs however, funding for studies into the legitimate uses for these substances has been hard to come by. Many studies are now being performed testing the efficacy of MDMA in treating a variety of mental health conditions. Studies begun by the California-based Multidisciplinary Association for Psychedelic Studies aimed to show efficacy in treatment of mental health disorders such as PTSD and anxiety. Many recreational users of psychedelic drugs report long-term changes to mood and overall emotional well-being.

MDMA, commonly referred to as Ecstasy was used primarily as an adjunct to psychotherapy. Beginning in the 1980s MDMA saw an increase in street usage and became a popular club and rave drug. It was listed as a Schedule 1 drug in 1985, halting legitimate medical study for a period of time.

TYT Politics reporter Michael Tracey interviews the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), Rick Doblin. Learn more about Multidisciplinary Association for Psychedelic Studies (MAPS) here:

Follow Rick Doblin on Twitter:

Author: Hash Borgir

Hash is a Software Developer, tech geek, and psychedelic explorer with a passion for writing about plant medicines, psychology, consciousness, linux, web development, hacking and sciene related topics.